Page last updated: 2024-09-03

snp nonapeptide and Cardiomyopathy, Dilated

snp nonapeptide has been researched along with Cardiomyopathy, Dilated in 1 studies

*Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Arafat, M; Diaz, N; Etzion, Y; Gavidia, AA; Kapiloff, MS; Karakikes, I; Levitas, A; Mercola, M; Muhammad, E; Parvari, R; Perea Gil, I; Serrano, R; Zhang, Y1

Other Studies

1 other study(ies) available for snp nonapeptide and Cardiomyopathy, Dilated

ArticleYear
A Novel Recessive Mutation in SPEG Causes Early Onset Dilated Cardiomyopathy.
    PLoS genetics, 2020, Volume: 16, Issue:9

    Topics: Adolescent; Age of Onset; Calcium; Cardiomyopathy, Dilated; Cells, Cultured; Child; Child, Preschool; Exome Sequencing; Female; Gene Editing; Genes, Recessive; Heat-Shock Proteins; Homozygote; Humans; Induced Pluripotent Stem Cells; Infant; Male; Muscle Proteins; Mutation; Myocardial Contraction; Myocytes, Cardiac; Pedigree; Peptide Fragments; Protein Serine-Threonine Kinases

2020